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The Institute for Health Metrics and
Evaluation (IHME) and its partners re-
cently completed what is probably the
largest ever exercise undertaken in epide-
miological modelling, the Global Burden
of Disease 2010 (GBD-2010) estimates [1].
These estimates attempt to characterise
loss of health from disease and injury,
including the effects of some major risk
factors, on a global basis. They will find
widespread use in coming years and
influence developments in global health.
However, it is important to realise that
‘‘estimates are estimates, and not mea-
surements’’; they may perform better in
some respects than others [2]. Here, as a
group of independent experts, we com-
ment on some of the major issues raised by
this important work, while noting that it is
impossible to cover all the wealth of detail
involved in any critique. We take collective
responsibility for these views, though
many specific points come from individual
specialists among the authors.
What Are the Underlying Data
and Uncertainties for GBD-
2010?
There is sparse description of the source
database compiled for GBD-2010, and it is
not publicly available. The most detailed
overview of the underlying data comes
from a single quote: ‘‘We have included
almost 800 million deaths from 1950 to
2010, and the data come from different
sources. The goal was to incorporate ‘all
the available data’’’ [3]. As the GBD-2010
group acknowledges, these data in fact
correspond to only around 30% of global
deaths over the whole period, and are a
mixture of survey data, sample registra-
tion, and vital registration [4]. According to
World Health Organization (WHO) data,
vital registration coverage has risen in
recent years to around 40% of global
deaths, but with a very unequal global
distribution, as shown by GBD-2010 region
in Figure 1. Consequently, the majority of
the deaths in the GBD-2010 database must
have come from areas with fairly complete
vital registration, though no doubt the
sophisticated GBD-2010 modelling adjusts
for this bias as far as possible. However,
more than 30% of the world’s population
live in regions where less than 5% of all
deaths are registered—a critical ongoing
concern for understanding global health
[5]. Since GBD-2010 included all possible
data, it is difficult to determine the external
validity of the findings beyond the available
data, or to establish the overall validity of
the estimates.
A good development across all the
GBD-2010 work is the 95% uncertainty
intervals calculated around the results.
However, given the complex nature of
the modelling for the point estimates, these
intervals are also complex. In Figure 2, as
an example, the mortality rates for diabe-
tes are shown, by GBD-2010 region, with
their uncertainty intervals. Interestingly, in
regions where there are only scant data on
diabetes mortality, such as in sub-Saharan
Africa, the intervals are not appreciably
wider than in other regions with much
more comprehensive data, suggesting that
the uncertainty intervals reflect more of
the internalities of the modelling rather
than the quality and quantity of source
data. Understanding the construction and
interpretation of this plethora of GBD-
2010 uncertainty intervals remains an
ongoing challenge.
Building on Previous Global
Burden of Disease Work
The GBD-2010 team, at the London
launch event in December 2012, empha-
sised that GBD-2010 estimates supersede
previous estimates for earlier periods and
differ in some respects. Much has rightly
been made of substantial global increases
in the numbers of elderly people and the
impact of non-communicable disease
(NCD) in recent years. Nevertheless, given
the inevitability of NCD deaths at the
elder extremes of populations, isolating the
public health importance of premature
NCD morbidity and mortality also re-
mains critical.
The Essay section contains opinion pieces on topics
of broad interest to a general medical audience.
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The Ghana National Health Planning
Unit (NHPU), in the late 1970s, developed
a method whereby the health impact of
different disease problems could be esti-
mated quantitatively [6]. This method
estimated loss of healthy life due to death,
disablement, and illness for about 50
causes, which were then ranked. This
approach was similar methodologically to
Murray and Lopez’s subsequent first
attempt to assess healthy life lost due to
different diseases on a global basis [7].
It is interesting to compare these earlier
disease rankings for Ghana with GBD-
2010 estimates for 1990 and 2010, as well
as the WHO Burden of Disease findings
for 2004. Table 1 compares rankings for
the top fifteen GBD-2010 causes of lost
years of healthy life—disability-adjusted
life years (DALYs)—for Ghana in 2010
with the previous estimates [6,8]. Many
conditions maintain a relatively stable
ranking across all four estimates. There
are some stark differences with obvious
explanations, such as the burgeoning
burden of HIV/AIDS and the remarkable
success of measles vaccination pro-
grammes. However, rankings for anaemia
and diarrhoea vary widely, and sickle cell
disorders are ranked substantially higher
in the 1980 NHPU estimates than in the
GBD-2010 estimates, even though the
prevalence of this genetically determined
condition in West Africa cannot have
changed markedly. These latter examples
illustrate the difficulties of translating
various estimates into policy, being unsure
whether differences reflect changes in
methods and data, or real transitions.
Biomedical Plausibility
GBD-2010 has fitted all diseases and
injuries into a 291-cause hierarchy that
incorporates 235 causes of death [9]. This
approach is inevitably a simplification of
what happens in real life, whilst many
individual episodes of disease and causes of
death may not in reality be diagnosed and
documented with sufficient precision to be
categorised even within this framework.
Some region-age-sex disease categories
may not therefore be attributed with
certainty. This is reflected in GBD-2010
by over 56,000 deaths in 2010 estimated to
be in region-age-sex categories where the
lower bound of the 95% uncertainty
interval is zero, presumably indicating that
there were possibly no such cases. Eighty-
six of these zero-bound categories each
related to more than 100 possible cases of
otitis media, diphtheria, whooping cough,
varicella, schistosomiasis, and other hae-
moglobinopathies.
Some potentially important sub-catego-
ries of disease have not been included in
GBD-2010. For example, there is no
distinction made between infections with
different species of malaria parasite, even
though there are important geographic
and clinical differences between Plasmodi-
um falciparum and P. vivax disease. Some
causes of disease have been aetiologically
defined (for example, shigellosis) even
though—particularly when using data
sources such as verbal autopsy (VA, where
cause of death is determined by interview-
ing witnesses)—these may be attributed on
a presumptive basis from symptoms.
Several pathogen-specific categories, for
example, various aetiologies of respiratory
infections, seem to have relative estimates
that differ from established knowledge,
and this remains an area for further
discussion. In addition, the relatively
short-term effects of some new vaccines
may shift disease patterns faster than
would otherwise be expected, which may
be difficult to model. Conversely, there
may be dangers in relying too heavily on
Summary Points
N Health data include many gaps, particularly relating to poorer areas of the
world, so complex estimation techniques are needed to get overall global
pictures.
N Estimates of population health, however, carry their own uncertainties and may
be flawed in some instances.
N Here we present a range of reflections on the Global Burden of Disease 2010
estimates, highlighting their strengths as well as challenges for potential users.
N In the long term, there can be no substitute for properly counting and
accounting for all the world’s citizens, so that complex estimation techniques
are not needed.
Figure 1. Proportions of deaths covered by vital registration, shown by GBD-2010 regions. Data from [20]; unregistered deaths from the
2010 Haiti earthquake excluded.
doi:10.1371/journal.pmed.1001477.g001
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GBD-2010 estimates as a basis for major
policy decisions, such as the introduction
of new vaccines.
The consequences of the HIV/AIDS
pandemic are a major difficulty for global
estimates. Morbidity and mortality data are
commonly not linked to individual evi-
dence on HIV status, other than in specific
contexts such as the ALPHA Network [10],
and so modelling the effects of HIV on
overall estimates can be misleading.
The Dynamics of Maternal
Mortality
Evidence of the dynamic nature of
maternal mortality goes back centuries in
some parts of the world. However, changes
in the magnitude, causes, broader determi-
nants, and risk groups of maternal mortality
are only just emerging at the global level,
since improved data sources and analytic
methods are recent developments for many
low-income countries. These changes in
maternal mortality reflect the benefits of
interventions such as family planning and
emergency obstetric care, as well as the
neglect of emerging causes of disease such
as NCDs, and have major programmatic
implications for the future. Exercises like
GBD-2010 can undoubtedly help to both
illuminate shifts and inform programme
responsiveness. To realise this opportunity
requires not only deeper probing of the
data, but, crucially, engagement and em-
powerment of stakeholders in low-income
countries to move the evidence into
action.
GBD-2010 revitalises the metric of age-
specific mortality rates for women of
reproductive age, rather than considering
maternal deaths in isolation, and this is
welcome. However, since pregnancy is not
included among the GBD-2010 risk factors
[11], the GBD-2010 estimates do not
address indirect maternal deaths, and
hence do not contribute to understanding
interactions between pregnancy and HIV/
AIDS in terms of mortality [12]. GBD-
2010 can help show where there is
improved access to quality maternity ser-
vices (evident from declines in total deaths)
and better use of family planning (faster
declines in some age-specific mortality
rates). However, family planning use also
changes the natural composition of the
cohort of childbearing women, including
those at higher risk. For example, in
Jamaica between 1981 and 2011, absolute
births declined faster (233.7%) than ma-
ternal deaths (231.7%), resulting in a
stagnating maternal mortality ratio. More
support needs to be available for countries
to work with GBD-2010 estimates and
better understand the consequences of the
dynamic burden of maternal mortality.
Why Are Injuries Important in
GBD-2010?
Apart from making important contribu-
tions to morbidity and mortality worldwide,
injuries as a health problem have special
characteristics and are heterogeneous.
Some mechanisms of injury, such as falls,
occur more commonly with increasing
proportions of elderly people in popula-
tions. Others are more random—as indi-
cated by the profile of pedestrians injured
by motor vehicles. Patterns of some types of
injury are influenced by technological
Figure 2. Diabetes mortality rates per 100,000 (with 95% uncertainty intervals) by GBD-2010 region for 2010. Data from [21].
doi:10.1371/journal.pmed.1001477.g002
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developments—increased speed, mechan-
isation, and industrialisation—while others
may be socio-medically determined—such
as suicide. All such factors make estimates
of injuries complex.
Risk factors and causes of injuries are
generally not well captured by the indica-
tors utilised in GBD-2010, which focus on
health risk behaviours and particular
environmental exposures. Road traffic
injuries, for instance, cannot be easily
predicted or understood in light of those
factors. Although alcohol is an acknowl-
edged risk factor for road traffic crashes,
motorisation, speed, and mixed traffic are
far more important.
Injuries are just as much a challenge for
the health sector as other GBD-2010
outcomes, though the health sector seldom
considers determinants of injury as its
responsibility [13]. From the DALYs
presented, addressing the consequences
of injuries in a timely manner (pre-hospital
and hospital care) and providing rehabil-
itation to victims are imperatives. Not
doing these brings the expense and burden
of increased—and preventable—disability.
Continuing Controversies in
Malaria
Ahead of GBD-2010, IHME published
separate estimates for the global burden of
malaria [14]. Most controversially these
suggested a much higher burden of malaria
among adults than most experts expected.
GBD-2010 to a large extent repeats the
earlier IHME estimates for malaria, though
there are some differences—and it is impor-
tant to realise that this is not an independent
confirmation of the earlier results. The
continuing debate on the reality of the global
malaria burden is, however, important [15].
There is agreement among malaria
scientists on the lack of sufficient informa-
tion on malaria-related deaths, especially
in endemic countries where most of the
deaths take place at home and many of the
dead are buried without having being seen
by a qualified healthcare provider. These
circumstances make it hard to account for
every death and even more difficult to
determine cause of death. Irrespective of
this unfortunate situation, efforts geared
towards improving data availability seem
to have been very limited relative to the
extent of the problem.
While good health information systems
might measure malaria-related mortality,
only a small minority of malaria deaths occur
within well-functioning healthcare systems,
especially in sub-Saharan Africa. IHME’s
estimates of adult malaria mortality were
partly based on a global VA series of more
than 12,000 deaths at referral facilities, but
which contained only 100 adult malaria
deaths, mostly from India [16]. Alternative
population-based approaches such as IN-
DEPTH’s health and demographic surveil-
lance systems are important for capturing—
using VA—deaths that occur outside the
healthcare system [17]. Despite possible limi-
tations of VA for detecting malaria deaths, it
is currently the only option for most cases.
Ways Forward
While GBD-2010 is undoubtedly a mas-
sive achievement for global health, our
discussion above also reveals continuing
concerns. WHO Director General Dr.
Margaret Chan observed ‘‘We must not
Table 1. Top fifteen ranked, and selected other, causes of disability-adjusted life years for Ghana from GBD-2010 for 2010,
compared with rankings from NHPU for 1980, GBD-2010 for 1990, and WHO Burden of Disease for 2004.
Cause of DALYs
NHPU
1980a
GBD-2010
for 1990b
WHO Burden of
Disease 2004c GBD-2010 for 2010b
Malaria 1 1 1 1
HIV/AIDS — 7 2 2
Lower respiratory infections 2 2 4 3
Neonatal sepsis 22d 5 5 4
Preterm birth complications 6 6 7 5
Protein-energy malnutrition 5 8 20 6
Neonatal encephalopathy 7 9 6 7
Iron-deficiency anaemia 34e 11 23 8
Stroke 11 12 13 9
Meningitis 19 10 35 10
Diarrhoeal diseases 9 3 3 11
Road injury 8f 16 13 12
Ischaemic heart disease 31 17 16 13
Major depressive disorder 42 15 12 14
Epilepsy — 19 25 15
Tuberculosis 10 13 9 17
Measles 3 4 44 36
Sickle cell disorders 4 20 - 24
Maternal causes 15 18 8 21
aData from [6].
bData from [22].
cData from [23].
dDid not include all infections.
eHookworm anaemia.
fIncludes all causes of injury.
doi:10.1371/journal.pmed.1001477.t001
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forget that the real need is to close the data
gaps, especially in low-income and middle-
income countries, so that we no longer have
to rely heavily on statistical modelling for
data on disease burden. We know that this
will require stronger country health infor-
mation systems, such as registration of births
and deaths’’ [18]. A subsequent expert
consultation convened by WHO in Geneva
in February 2013 called for greater capacity
investment in country-based estimates and
standards of transparency [19]. As the more
detailed material from GBD-2010 continues
to be released, and possibly superseded by
future revisions, there will also be continuing
questions about the validity, reliability,
transparency, and plausibility of the GBD-
2010 findings. Planners and policy-makers,
in particular, need to come to an under-
standing of how much reliance they should
reasonably place on these estimates, espe-
cially in data-sparse countries.
Acknowledgments
The authors are listed in alphabetical order. We
are grateful to colleagues who contributed to
discussions on various parts of this work.
Author Contributions
Wrote the first draft of the manuscript: PB
MdeC WJG LL AM-B OAS SMT BZ.
Contributed to the writing of the manuscript:
PB MdeC WJG LL AM-B OAS SMT BZ.
ICMJE criteria for authorship read and met: PB
MdeC WJG LL AM-B OAS SMT BZ. Agree
with manuscript results and conclusions: PB
MdeC WJG LL AM-B OAS SMT BZ.
References
1. Horton R (2012) GBD 2010: understanding
disease, injury and risk. Lancet 380: 2053–2054.
2. Byass P (2010) The imperfect world of global
health estimates. PLoS Med 7: e1001006.
doi:10.1371/journal.pmed.1001006
3. Das P, Samarasekera U (2012) The story of GBD
2010: a ‘‘super-human’’ effort. Lancet 380: 2067–
2070.
4. Wang H, Dwyer-Lindgren L, Lofgren KT,
Rajaratnam JK, Marcus JR, et al. (2012) Age-
specific and sex-specific mortality in 187 coun-
tries, 1970–2010: a systematic analysis for the
Global Burden of Disease Study 2010. Lancet
380: 2071–2094.
5. Byass P (2012) The UN needs joined-up thinking
on vital registration. Lancet 380: 1643.
6. Ghana Health Assessment Project Team (1981) A
quantitative method of assessing the health
impact of different diseases in less developed
countries. Int J Epidemiol 10: 73–80.
7. Murray CJL, Lopez AD, editors (1996) The
global burden of disease: a comprehensive
assessment of mortality and disability from
diseases, injuries, and risk factors in 1990 and
projected to 2020: summary. Cambridge (Massa-
chusetts): Harvard School of Public Health on
behalf of the World Health Organization and the
World Bank.
8. Murray CJL, Vos T, Lozano R, Naghavi M,
Flaxman AD, et al. (2012) Disability-adjusted life
years (DALYs) for 291 diseases and injuries in 21
regions, 1990–2010: a systematic analysis for the
Global Burden of Disease Study 2010. Lancet
380: 2197–2223.
9. Murray CJL, Ezzati M, Flaxman AD, Lim S,
Lozano R, et al. (2012) GBD 2010: design,
definition and metrics. Lancet 380: 2063–2066.
10. Zaba B, Marston M, Crampin AC, Isingo R,
Biraro S, et al. (2007) Age-specific mortality
patterns in HIV-infected individuals: a compar-
ative analysis of African community study data.
AIDS 21 (Suppl 6): S87–S96.
11. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya
K, et al. (2012) A comparative risk assessment of
burden of disease and injury attributable to 67
risk factors and risk factor clusters in 21 regions,
1990–2010: a systematic analysis for the Global
Burden of Disease Study 2010. Lancet 380:
2224–2260.
12. Zaba B, Calvert C, Marston M, Isingo R,
Nakiyingi-Miiro J, et al. (2013) Effect of HIV
infection on pregnancy-related mortality in sub-
Saharan Africa: secondary analyses of pooled
community based data from the network for
Analysing Longitudinal Population-based HIV/
AIDS data on Africa (ALPHA). Lancet 381:
1763–1771.
13. Laflamme L, Sethi D, Burrows S, Hasselberg M,
Racioppi F, et al. (2009) Addressing the socieco-
nomic safety divide: a policy briefing. Copenha-
gen: World Health Organization Regional Office
for Europe. Available: http://www.euro.who.
int/__data/assets/pdf_f i le/0004/96457/
E92197.pdf. Accessed 7 April 2013.
14. Murray CJL, Rosenfeld LC, Lim SS, Andrews
KG, Foreman KJ, et al. (2012) Global malaria
mortality between 1980 and 2010: a systematic
analysis. Lancet 379: 413–431.
15. Ye Y, Kyobutungi C, Ogutu B, Villegas L, Diallo
D, et al. (2013) Malaria mortality estimates: need
for agreeable approach. Trop Med Int Health 18:
219–221.
16. Murray CJL, Lopez AD, Black R, Ahuja R, Ali
SM, et al. (2011) Population Health Metrics
Research Consortium gold standard verbal au-
topsy validation study: design, implementation
and development of analysis datasets. Popul
Health Metr 9: 27.
17. Sankoh O, Byass P (2012) The INDEPTH
Network: filling vital gaps in global epidemiology.
Int J Epidemiol 41: 579–588.
18. Chan M (2012) From new estimates to better
data. Lancet 380: 2054.
19. World Health Organization (2013) Global health
estimates: proposals on the way forward. Geneva:
World Health Organization. Available: http://
www.who . in t/en t i t y/hea l th in fo/GHE_
MeetingSummary_Feb2013.pdf. Accessed 7 April
2013.
20. World Health Organization (2013) Global Health
Observatory Data Repository [database]. Avail-
able: http://apps.who.int/gho/data/. Accessed
24 May 2013.
21. Institute for Health Metrics and Evaluation (2013)
GBD 2010 cause of death by region 1990–2010
[ d a t a b a s e ] . A v a i l a b l e : h t t p : / / ghd x .
healthmetricsandevaluation.org/sites/ghdx/files/
record-attached-files/IHME_GBD_2010_COD_
BY_REGION_1990_2010.ZIP. Accessed 24
May 2013.
22. Institute for Health Metrics and Evaluation (2013)
GBD arrow diagram [database]. Available:
http://www.healthmetricsandevaluation.org/
gbd/visualizations/gbd-arrow-diagram. Accessed
24 May 2013.
23. World Health Organization (2013) Health statis-
tics and health information systems: disease and
injury country estimates—burden of disease
[database]. Available: http://www.who.int/
healthinfo/global_burden_disease/estimates_
country/en/index.html. Accessed 24 May 2013.
PLOS Medicine | www.plosmedicine.org 5 July 2013 | Volume 10 | Issue 7 | e1001477
